Article Figures & Data
Figures
- Fig 1.
Female patient with small AVM completely occluded in one session. Bleeding 19 hours after embolization.
- Fig 2.
Venous passage of embolic agent. Bleeding 24 hours after embolization.
- Fig 3.
Differences in the distribution of AVM reduction in one session in patients (interventions) with and without (w/o) a bleeding complication.
- Fig 4.
Different age distribution of patients with and without postinterventional bleeding.
Tables
- Table 1:
Comparison of AVM size, reduction in one session, and age of patients with and without a bleeding complication
All Patients(All Interventions) Patients with Bleeding (Interventions with Bleeding) AVM size <3 cm3 26/66 (36/125) 6/6 (6/7) AVM reduction >60% 30/66 (32/125) 5/6 (6/7) Age of patients >50 y 13/66 (22/125) 3/6 (3/7) - Table 2:
Comparison of postinterventional monitoring of patients with and without a bleeding complication
Patients w/o Bleeding (Interventions) Patients with Bleeding (Interventions) Interdisciplinary operative intensive care unit 44 (92) 1 (2) Stroke unit 13 (21) 3 (3) Medical intensive care unit 3 (5) 2 (2)
In this issue
Jump to section
Related Articles
Cited By...
- Complications of Endovascular Treatments for Brain Arteriovenous Malformations: A Nationwide Surveillance
- Evaluation of 4D Vascular Flow and Tissue Perfusion in Cerebral Arteriovenous Malformations: Influence of Spetzler-Martin Grade, Clinical Presentation, and AVM Risk Factors
- Direct continuous measurement of draining vein pressure during Onyx embolization in a swine arteriovenous malformation model
- Angioarchitectural Characteristics Associated with Complications of Embolization in Supratentorial Brain Arteriovenous Malformation
- Reporting standards for angiographic evaluation and endovascular treatment of cerebral arteriovenous malformations
- Periprocedural blood pressure management in neurointerventional surgery
- Superior vena cava syndrome caused by embolisation of liquid Onyx
- Embolization of Intracranial Arteriovenous Malformations with Ethylene-Vinyl Alcohol Copolymer (Onyx)